Last reviewed 2026-06-10 · How we verify

Relief of symptoms of runny nose — Treatment Landscape & Competitive Intelligence

Relief of symptoms of runny nose (disease) competitive landscape: 1 marketed treatments tracked, 0 Phase 3 candidates, 0 Phase 2 candidates. Recent regulatory actions and upcoming PDUFA dates across the entire treatment set.

Marketed treatment landscape

Approved drugs treating Relief of symptoms of runny nose, deduplicated by molecule. See the full disease page for line-of-therapy detail.

Phase 3 pipeline

No Phase 3 pipeline candidates tracked.

Phase 2 pipeline

No Phase 2 pipeline candidates tracked.

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this treatment set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this treatment set.

Sponsor landscape

1. Pfizer · 1 drug in Relief of symptoms of runny nose

Subscribe to ongoing alerts

Every new regulatory action, PDUFA date, or trial completion in Relief of symptoms of runny nose:

• Relief of symptoms of runny nose treatment updates — RSS
• Relief of symptoms of runny nose treatment updates — Atom
• Relief of symptoms of runny nose treatment updates — JSON

Cite this brief

Drug Landscape (2026). Relief of symptoms of runny nose — Treatment Landscape & Competitive Intelligence Brief. https://druglandscape.com/ci/disease/relief-of-symptoms-of-runny-nose. Accessed 2026-06-10.

Related

• Relief of symptoms of runny nose full disease profile — treatment pathway, diagnostics, guidelines
• Browse all CI briefs
• Build a custom feed

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing